Analytical Data
-
Gene name
SLC30A5
- Application
-
Alternative Names
ZTL1; ZnT-5; ZNT5; ZNTL1; Zinc Transporter 5; ZnT-like transporter 1
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8R4H9
-
Expression Region
Asp639~Leu751
-
Molecular Weight
15kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC30A5, also known as zinc transporter 5 (ZnT5), is a critical member of the SLC30 family of zinc transporters involved in the cellular homeostasis of zinc, an essential trace element necessary for various biological processes. Dysregulation of zinc transport can lead to various health issues, including metabolic disorders, neurodegenerative diseases, and impaired immune function. Recent studies have shown that SLC30A5 plays a vital role in zinc influx and efflux in specific tissues, particularly in the pancreas, where it may influence insulin secretion and glucose metabolism. The recombinant protein of SLC30A5 has garnered attention in research for its potential role in therapeutic applications and its implications in diseases related to zinc dysregulation. By producing and characterizing recombinant SLC30A5 protein, researchers aim to elucidate its functional mechanisms, explore its structure-function relationship, and identify potential interactions with other biomolecules. Such studies could pave the way for developing new strategies for diagnosing and treating conditions linked to zinc imbalance, highlighting the importance of SLC30A5 in maintaining zinc homeostasis and overall metabolic health.
